Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Genetec's earnings per share without non-recurring items for the
six
months ended in Mar. 2026 was 円35.45.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 円41.90.
During the past 12 months, Genetec's average earnings per share (NRI) Growth Rate was 12.90% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 135.10% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 38.70% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Genetec's EPS without NRI or its related term are showing as below:
TSE:4492'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -47.5 Med: 32.55 Max: 135.1
Current: 135.1
During the past 9 years, Genetec's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 135.10% per year. The lowest was -47.50% per year. And the median was 32.55% per year.
TSE:4492's 3-Year EPS without NRI Growth Rate is ranked better than 97.74% of 2077
companies
in the Software industry
Industry Median: 12.5
vs TSE:4492: 135.10
Genetec's EPS (Diluted) for the
six
months ended in Mar. 2026 was 円36.39.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円43.78.
Genetec's EPS (Basic) for the
six
months ended in Mar. 2026 was 円36.83.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was 円44.26.
Genetec (TSE:4492) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Genetec EPS without NRI Related Terms
Genetec EPS without NRI Historical Data
* Premium members only.
The historical data trend for Genetec's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4492 vs UBER, SHOP, CRM: EPS without NRI Comparison
For the Software - Application subindustry, Genetec's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genetec PE Ratio without NRI vs Software Industry
For the Software industry and Technology sector, Genetec's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Genetec's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円41.90
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genetec (TSE:4492) has a EPS without NRI of 円41.90 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Genetec and its competitors. According to the industry distribution chart, Genetec ranks #47 out of 2077 companies in the Software industry, placing it in the top 2.3%.
Is Genetec's EPS without NRI too high?
Genetec's current EPS without NRI is 円41.90. Based on the distribution chart, Genetec ranks #47 out of 2077 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Genetec has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genetec's EPS without NRI compare to UBER and SHOP?
According to the Software industry distribution chart, Genetec ranks #47 out of 2077 companies for EPS without NRI. This places Genetec in the top 2% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 12.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Software company?
The median EPS without NRI among Software companies is 12.50, based on 2,077 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Genetec and its competitors. For the Software industry, the median EPS without NRI is 12.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genetec's current EPS without NRI is 円41.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genetec stock overvalued right now?
Based on GuruFocus' analysis, Genetec (TSE:4492) is currently considered Significantly Undervalued. The stock's GF Value™ is 円759.98, compared to a current price of 円419.00 — trading 44.9% below its estimated fair value. The current EPS without NRI is 円41.90. Genetec's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Genetec (TSE:4492), the current EPS without NRI is 円41.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genetec (TSE:4492) Overvalued in 2026?
Based on GuruFocus' analysis, Genetec stock appears to be undervalued.
The current stock price of 円419.00 is trading 44.9% below its estimated GF Value™ of 円759.98.
GuruFocus considers Genetec to be Significantly Undervalued.
Key valuation signals for TSE:4492:
EPS without NRI: 円41.90
GF Value™: 円759.98 vs. price of 円419.00 (44.9% below fair value)
No single metric tells the full story. See the TSE:4492 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genetec Corp is engaged in the provision of system development, engineering, and IOT/cloud solutions. Its services include software development, hardware development, engineering solutions, Mastercam, Robomaster, flexisim, IoT/M2M business, surve-I, Coco Dayo, and web integration.
77GF Score
Get the complete analysis for TSE:4492
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4492 has been successfully added to your 
